Democratizing hedge fund level analysis tools for everyone
Name | Phapros Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Kimia Farma Tbk | 56.77 | 56.77 |
Public < 5% | 32.77 | 32.83 |
Masrizal A. Syarief | 10.46 | 10.39 |
Others | 0.01 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Generic Drugs Bearing | 51.9% | 47.5% |
Ethical | 28.3% | 31.9% |
Over The Counter | 18.1% | 18.7% |
Toll-in | 1.8% | 2.0% |
Others | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 0.30 | # 4 / 15 |
EV_EBITDA | 11.02 | # 6 / 15 |
PER | 58.10 | # 11 / 15 |
PBV | 0.70 | # 2 / 15 |
DER | 2.69 | # 10 / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | 0.5 | # 11 / 15 |
ROA % | 0.3 | # 11 / 15 |
ROE % | 1.2 | # 12 / 15 |
Year | DPS | Yield [%] |
---|---|---|
2023 | 13.4 | 2.1 |
2022 | 7.9 | 1.2 |
2021 | 23.1 | 2.1 |
2020 | 85.0 | 5.0 |
2019 | 110.3 | 10.3 |
Timeframe | Performance |
---|---|
1W % | -2.9 |
1Mo % | 1.2 |
3Mo % | 25.0 |
1Yr % | -5.7 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
PEHA | 58.10 | 286 B | 1.30 T | 916 B | 117 B | 5 B |
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |